Category

• Products3

Organizations

• Bausch + Lomb66
• Eyes On Eyecare47
• Alcon, Inc.44
• American Optometric Association35
• Harrow29
• Glaukos26
• Regeneron23
• Topcon Healthcare23
• Aldeyra Therapeutics20
• Sight Sciences19

Tags

• FDA3
• Fda Approval3
• Eye Drop Solution3
• Eye Drops3
• Products2
• IOP1
• Ocular Hypertension1
• Dry Eye1
• Dry Eye Disease1
• Generics1

• Organizations: Amneal Pharmaceuticals✕

Clear all

Products

Amneal receives FDA approval for Restasis generic

Generic version of Allergan’s cyclosporine ophthalmic emulsion 0.05% eye drop for dry eye is the second to receive U.S. regulatory clearance.

Products

FDA approves Amneal's bimatoprost 0.01% generic

Generic version of Allergan’s LUMIGAN is indicated for reducing elevated IOP in glaucoma and ocular hypertensive patients.

Products

FDA approves Amneal's prednisolone acetate ophthalmic suspension

Referencing Allergan's Pred Forte, this 1% concentrated drop is expected to hit the U.S. market by Q3 2025.